How to buy Hill-Rom stock (HRC)

Hill-Rom is a medical instruments & supplies business based in the US. Hill-Rom shares (HRC) are listed on the NYSE and all prices are listed in US Dollars. Hill-Rom employs 10,000 staff and has a trailing 12-month revenue of around $3 billion.

Our top picks for where to buy Hill-Rom stock

Buy Hill-Rom stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Hill-Rom stock price (NYSE: HRC)

Use our graph to track the performance of HRC stocks over time.

Hill-Rom shares at a glance

• Key figures

Information last updated 2022-02-06.

52-week range	$0.00 - $0.00
50-day moving average more info button	$154.34
200-day moving average more info button	$130.22
Wall St. target price	$156.00
PE ratio more info button	41.9247
Dividend yield more info button	$0.94 (0.62%)
Earnings per share (TTM) more info button	$3.72

Is it a good time to buy Hill-Rom stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is Hill-Rom stock undervalued or overvalued?

Valuing Hill-Rom stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Hill-Rom's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Hill-Rom's P/E ratio

Hill-Rom's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 42x. In other words, Hill-Rom shares trade at around 42x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Hill-Rom's PEG ratio

Hill-Rom's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.71. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Hill-Rom's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

Hill-Rom's EBITDA

Hill-Rom's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $645.3 million.

The EBITDA is a measure of a Hill-Rom's overall financial performance and is widely used to measure a its profitability.

Hill-Rom financials

Revenue TTM	$3 billion
Operating margin TTM	15.7%
Gross profit TTM	$1.6 billion
Return on assets TTM	6.13%
Return on equity TTM	13.78%
Profit margin	8.23%
Book value	$28.53
Market Capitalization more info button	$10.3 billion

TTM: trailing 12 months

Hill-Rom share dividends

Dividend payout ratio: 15.21% of net profits

Recently Hill-Rom has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Hill-Rom shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Hill-Rom's case, that would currently equate to about $0.94 per share.

While Hill-Rom's payout ratio might seem low, this can signify that Hill-Rom is investing more in its future growth.

Hill-Rom's most recent dividend payout was on 30 December 2021. The latest dividend was paid out to all shareholders who bought their shares by 13 December 2021 (the "ex-dividend date").

Have Hill-Rom's shares ever split?

Hill-Rom's shares were split on a 2:1 basis on 1 March 1992 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Hill-Rom shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Hill-Rom shares which in turn could have impacted Hill-Rom's share price.

Hill-Rom share price volatility

Over the last 12 months, Hill-Rom's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Hill-Rom's is 0.5532. This would suggest that Hill-Rom's shares are less volatile than average (for this exchange).

Hill-Rom overview

Hill-Rom Holdings, Inc. operates as a medical technology company worldwide. The company operates through Patient Support Systems, Front Line Care, and Surgical Solutions segments. It offers medical surgical beds, intensive care unit beds, and bariatric patient beds, patient mobility solutions, non-invasive therapeutic products and surfaces, and information technologies and software solutions, as well as sells equipment service contracts for its capital equipment. The company also provides patient monitoring and diagnostics products, such as patient exam and diagnostics, patient monitoring, diagnostic cardiology, vision screening, and diagnostics products; and respiratory health products comprising non-invasive devices that provide respiratory support and assist patients in the mobilization of retained blockages. In addition, it offers surgical solutions that include tables, lights, and pendants; and positioning devices for use in shoulder, hip, spinal, and lithotomy surgeries, as well as platform-neutral positioning accessories for operating room tables. Further, the company sells and rents products to acute and extended care facilities through direct sales force and distributors; sells and rents products directly to patients in the home; and sells products to primary care facilities through distributors.

Frequently asked questions

null
What percentage of Hill-Rom is owned by insiders or institutions?
Currently 0.18% of Hill-Rom shares are held by insiders and 84.381% by institutions. How many people work for Hill-Rom?
Latest data suggests 10,000 work at Hill-Rom. When does the fiscal year end for Hill-Rom?
Hill-Rom's fiscal year ends in September. Where is Hill-Rom based?
Hill-Rom's address is: 130 East Randolph Street, Chicago, IL, United States, 60601 What is Hill-Rom's ISIN number?
Hill-Rom's international securities identification number is: US4314751029 What is Hill-Rom's CUSIP number?
Hill-Rom's Committee on Uniform Securities Identification Procedures number is: 431573104